1. Evolving concepts in the systemic drug therapy of breast cancer;Norton;Semin Oncol,1997
2. High-dose chemotherapy for primary breast cancer: facts and anecdotes;Hortobagyi;J Clin Oncol,1999
3. Improved outcomes from adding sequential Paclitaxel but not from escalating Doxorubicin dose in an adjuvant chemotherapy regimen for patients with node-positive primary breast cancer;Henderson;J Clin Oncol.,2003
4. Fisher B, Bryant J, Wolmark N, Mamounas E, Brown A, Fisher ER, Wickerham DL, Begovic M, DeCillis A, Robidoux A, Margolese RG, Cruz AB Jr, Hoehn JL, Lees AW, Dimitrov NV, Bear HD. Effect of preoperative chemotherapy on the outcome of women with operable breast cancer J Clin Oncol, 16(8);1998 Aug:2672–85
5. NSABP protocol B-27. Preoperative doxorubicin plus cyclophosphamide followed by preoperative or postoperative docetaxel;Mamounas;Oncology (Huntingt),1997